Hyaluronic acid drives mesenchymal stromal cell-derived extracellular matrix assembly by promoting fibronectin fibrillogenesis-Reference-Cited by-同舟云学术

Hyaluronic acid drives mesenchymal stromal cell-derived extracellular matrix assembly by promoting fibronectin fibrillogenesis

Published:2021 Issue:35 Volume:9 Page:7205-7215
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Assunção Marisa¹²^ORCID,Yiu Chi Him Kendrick¹²^ORCID,Wan Ho-Ying¹²^ORCID,Wang Dan¹²³⁴^ORCID,Ker Dai Fei Elmer¹²³⁴^ORCID,Tuan Rocky S.¹²^ORCID,Blocki Anna¹²³^ORCID

Affiliation:

1. Institute for Tissue Engineering and Regenerative Medicine, The Chinese University of Hong Kong (CUHK), Shatin, Hong Kong SAR, China

2. School of Biomedical Sciences, CUHK, Shatin, Hong Kong SAR, China

3. Department of Orthopaedics & Traumatology, Faculty of Medicine, CUHK, Shatin, Hong Kong SAR, China

4. Key Laboratory for Regenerative Medicine, Ministry of Education, School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Abstract

Hyaluronic acid (HA) is present at sites of ongoing fibronectin fibrillogenesis (fibrillar adhesions) and necessary for efficient fibronectin fibrillogenesis. As a result, fibronectin deposition can be enhanced by exogenous HA.

Funder

Innovation and Technology Commission

Chinese University of Hong Kong

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D1TB00268F

Reference59 articles.

1. Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory

2. Hyaluronic acid, an efficient biomacromolecule for treatment of inflammatory skin and joint diseases: A review of recent developments and critical appraisal of preclinical and clinical investigations